Shelley Idziaszczyk
Publications by Year
Research Areas
Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial(2011)965 cited
- → Comprehensive Mutation Analysis of TSC1 and TSC2—and Phenotypic Correlations in 150 Families with Tuberous Sclerosis(1999)528 cited
- → Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33(2010)373 cited
- → Molecular Genetic and Phenotypic Analysis Reveals Differences between TSC1 and TSC2 Associated Familial and Sporadic Tuberous Sclerosis(1997)256 cited
- → A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer(2015)126 cited
- → Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer(2017)109 cited
- → Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis(2017)109 cited
- → Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab(2013)107 cited
- → Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer(2016)75 cited
- → A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma(2005)66 cited